Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation-Reference-Cited by-同舟云学术

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Published:2018-01-29 Issue:3 Volume:2 Page:200-209
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Shah Surbhi¹,Norby Faye L.²,Datta Yvonne H.¹,Lutsey Pamela L.²,MacLehose Richard F.²,Chen Lin Y.¹,Alonso Alvaro³

Affiliation:

1. Department of Medicine, University of Minnesota Medical School, Minneapolis, MN;

2. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN; and

3. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA

Abstract

Key Points In AF and cancer patients, rate of bleeding is lower with apixaban, similar in dabigatran and rivaroxaban users, compared to warfarin users. Ischemic stroke rates did not differ among anticoagulant users. Incident VTE risk was lower in all DOAC compared with warfarin users.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/2/3/200/880100/advances010694.pdf

Reference31 articles.

1. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

2. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum;Cardio-Oncology;2024-08-07

3. Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold;Journal of Clinical Medicine;2024-08-07

4. Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.);Hämostaseologie;2024-07-15

5. Characteristics and Management of Patients With Cancer and Atrial Fibrillation;JACC: Advances;2024-07